tiprankstipranks
Rapid Therapeutic Science Laboratories (RTSL)
OTHER OTC:RTSL
US Market
RTSL
Rapid Therapeutic Science Laboratories
RESEARCH TOOLSreports

Rapid Therapeutic Science Laboratories (RTSL) Income Statement

29 Followers

Rapid Therapeutic Science Laboratories Income Statement

Last quarter (Q ), Rapid Therapeutic Science Laboratories's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Rapid Therapeutic Science Laboratories's net income was $46.42K. See Rapid Therapeutic Science Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Mar 20Mar 19
Total Revenue
--$ 534.00$ 130.92K$ 9.14K$ 0.00
Cost of Revenue
--$ -534.00$ 19.39K$ 7.16K$ 0.00
Gross Profit
--$ 1.07K$ 111.52K$ 1.98K$ 0.00
Operating Expense
$ 405.69K$ 1.26M$ -4.35M$ 2.11M$ 434.99K$ 169.69K
Operating Income
$ 5.12M$ -2.53M$ 4.35M$ -1.99M$ -433.00K$ -169.69K
Net Non Operating Interest Income Expense
$ -277.44K$ -1.90M$ -1.38M$ -58.01K$ -191.58K$ -180.53K
Other Income Expense
$ -165.28K$ 531.39K$ -631.85K--$ 1.38K
Pretax Income
$ 59.56K$ -1.79M$ 2.97M$ -2.05M$ -624.58K$ -348.84K
Tax Provision
---$ 0.00$ 0.00-
Earnings From Equity Interest Net Of Tax
$ -857.13K-----
Net Income Common Stockholders
$ 4.14M$ -1.79M$ 101.68K$ -2.05M$ -624.58K$ -348.84K
Basic EPS
-$ -0.23-$ -0.25$ -0.01$ -0.29
Diluted EPS
-$ -0.23$ -0.50$ -0.25$ -0.01$ -0.29
Basic Average Shares
$ 31.79M$ 7.75M$ 7.63M$ 6.75M$ 60.02M$ 1.20M
Diluted Average Shares
$ 24.04M$ 7.75M$ 7.63M$ 6.75M$ 60.02M$ 1.20M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 405.69K$ 1.26M$ -4.35M$ 2.13M$ 442.14K$ 169.69K
Net Income From Continuing And Discontinued Operation
$ 3.37M$ -1.79M$ 101.68K$ -2.05M$ -624.58K$ -348.84K
Normalized Income
$ -719.08K--$ -2.05M$ -624.58K$ -350.22K
Interest Expense
$ 346.17K--$ 58.01K$ 191.58K$ 180.53K
EBIT
$ 626.56K$ 100.92K$ 4.29M$ -1.99M$ -433.00K$ -168.31K
EBITDA
$ 632.92K$ 124.90K$ -334.72K$ -1.91M$ -395.50K$ -168.31K
Currency in USD

Rapid Therapeutic Science Laboratories Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis